CTMX logo
CTMX NASDAQ US

CytomX Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 2015
$4.56
▲ +$0.00 (+0.00%)
Vol 4.7M
10
Quality Score
ok
Deep Check
1/5 fail
Mkt Cap
$721.8M
P/E
25.8
ROE
10.9%
Margin
24.7%
D/E
0.00
Beta
2.48
52W
$0–$5

Wall Street Consensus

15 analysts · Apr 2026
6
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
93.3%
Buy Rating

Price Chart

Similar Stocks

SVRA
Savara Inc
$1.2B
AVBP
ArriVent BioPharma Inc
$830.6M
GERN
Geron Corp
$842.6M
KALV
Kalvista Pharmaceuticals Inc
$816.3M
CMPX
Compass Therapeutics Inc.
$955.1M
AKTS
Aktis Oncology Inc
CDNA
CareDx Inc
P/E 15.9
$969.0M
INBX
Inhibrx Biosciences Inc
$1.1B

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.10 $-0.22 $-0.12
Sep 2025 $-0.05 $-0.09 $-0.04
Jun 2025 $-0.08 $0.00 +$0.08
Mar 2025 $0.13 $0.27 +$0.14

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 32.2% 32.2% 32.2% 32.2% 10.9% 10.9%
P/E (TTM) 7.45 6.94 11.58 12.27 23.40 25.76
Net Margin -0.8% 34.0% 34.0% 34.0% 24.7% 24.7%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 4.20 4.20 4.20 4.20 3.64 3.64

Key Ratios

ROA (TTM)
20.3%
P/S (TTM)
6.35
P/B
6.1
EPS (TTM)
$0.40
CF/Share
$-0.39
Rev Growth 3Y
+54.7%
52W High
$4.62
52W Low
$0.40
$0.40 52-Week Range $4.62

How does CTMX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CTMX AAPG ABEO ABOS ABP

CTMX valuation vs Biotechnology peers

P/E ratio
25.8
▲ 37% above peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
6.4
▼ 51% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
6.1
▲ 147% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CTMX profitability vs Biotechnology peers

ROE
10.9%
▲ 116% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
24.7%
▲ 109% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
20.3%
▲ 143% above peers (-46.7%)
vs Peers
vs Industry
Top tier

CTMX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.6
▼ 18% below peers (4.4)
vs Peers
vs Industry
Below avg
Beta
2.5
▲ 156% above peers (1.0)
vs Peers
vs Industry
More volatile

CTMX fundamentals radar

CTMX Peer median Industry

CTMX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CTMX vs peers: key metrics

Latest News

CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress
Yahoo Finance · Mar 29
Jefferies Raises CytomX Therapeutics (CTMX) Price Target to $16
Yahoo Finance · Mar 22